Income Statement
MINERALYS THERAPEUTICS, INC.
MLYS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
- | - | - |
|
Cost of Revenue
|
- | - | - |
|
Gross Profit
|
- | - | - |
|
Operating Expenses
|
170.60 | 192.40 | 84.66 |
|
Research & Development
|
132.01 | 168.58 | 70.36 |
|
Selling, General & Administrative
|
38.60 | 23.82 | 14.30 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-170.60 | -192.40 | -84.66 |
|
Non-Operating Income
|
15.95 | 14.59 | 12.76 |
|
Interest Income
|
- | - | - |
|
Interest Expense
|
- | - | - |
|
Other Non-Op Income / Expense
|
0.00 | 0.01 | - |
|
Income Before Tax
|
- | - | - |
|
Income Tax Expense
|
- | - | - |
|
Non-Controlling Interest
|
- | - | - |
|
Net Income
|
-154.65 | -177.81 | -71.90 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-170.55 | -192.36 | -84.66 |
|
Earnings Per Share (Basic)
|
-2.29 | -3.66 | -1.99 |
|
Diluted EPS
|
-2.29 | -3.66 | -1.99 |
|
Weighted Average Shares
|
67.66 | 48.54 | 36.19 |
|
Diluted Weighted Avg Shares
|
67.66 | 48.54 | 36.19 |
|
Comprehensive Income
|
- | - | - |